Drew S. Kern

Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease

Danna Jennings, Sarah Huntwork‐Rodriguez, Anastasia G. Henry et al. · Science Translational Medicine · 2022 · 230 citations

Long-term activity in upper- and lower-limb muscles of humans

Drew S. Kern, John G. Semmler, Roger M. Enoka · Journal of Applied Physiology · 2001 · 131 citations

Biocompatibility of poly(ethylene glycol)‐based hydrogels in the brain: An analysis of the glial response across space and time

Kimberly B. Bjugstad, Kyle J. Lampe, Drew S. Kern et al. · Journal of Biomedical Materials Research Part A · 2010 · 116 citations

Tissue Engineering, Ethylene Glycol, Engineering +17

Biocompatibility of PEG-Based Hydrogels in Primate Brain

Kimberly B. Bjugstad, D. Eugene Redmond, Kyle J. Lampe et al. · Cell Transplantation · 2008 · 100 citations · Full text

Tissue Engineering, Engineering, Biomaterials Design +16

The administration of BDNF and GDNF to the brain via PLGA microparticles patterned within a degradable PEG‐based hydrogel: Protein distribution and the glial response

Kyle J. Lampe, Drew S. Kern, Melissa J. Mahoney et al. · Journal of Biomedical Materials Research Part A · 2011 · 93 citations